Fact-checked by Grok 2 weeks ago

HeadOn

HeadOn is a homeopathic topical remedy marketed for the temporary relief of headache and migraine pain, consisting of a waxy stick containing diluted plant extracts that is applied directly to the forehead.^[1] The product's active ingredients are Iris versicolor root (12X HPUS, 0.2%) and Bryonia alba root (12X HPUS, 0.08%), both indicated as pain relievers in homeopathic pharmacopoeia, with inactive components including ethyl alcohol, propylene glycol, and menthyl lactate for application consistency.^[1] Distributed by Miralus Healthcare, based in Cheyenne, Wyoming, HeadOn is intended for external use only and is positioned as a non-greasy, invisible alternative to oral medications, safe for frequent application without drug interactions.^[1] Launched in 2006 by Miralus Healthcare, a Florida-based company at the time with manufacturing in Chicago, HeadOn quickly gained widespread recognition—and criticism—through its highly repetitive television advertisements featuring the tagline "HeadOn: Apply directly to the forehead" repeated multiple times without additional context or explanation.^[2] The commercials, which aired extensively on U.S. networks, were produced in response to regulatory scrutiny from the Better Business Bureau over earlier ads' unsubstantiated claims of "fast, safe, effective" relief, leading to the simplified, mantra-like format that emphasized application method over efficacy promises.^[3] This advertising strategy propelled HeadOn into pop culture notoriety, often cited as one of the most irritating and memorable commercials of the 2000s, while also drawing complaints for its lack of substantive information about the product.^[4] Despite its marketing success, HeadOn has faced significant skepticism regarding its effectiveness, as it relies on homeopathic dilutions far beyond Avogadro's limit, rendering the active ingredients effectively absent and providing no pharmacological basis for pain relief beyond potential placebo effects or the cooling sensation from menthol-like additives.^[5] Medical experts have cautioned that while the product poses minimal risk for most users when applied topically, it may delay proper treatment for serious headaches, and warnings on the label advise consulting a physician for persistent symptoms or skin sensitivities.^[3] The brand was available over-the-counter in the United States until its discontinuation in the 2010s for unknown reasons, continuing to embody debates over homeopathy's validity in modern medicine.^[1]

Product Overview

Description and Ingredients

HeadOn is a homeopathic topical remedy designed for the temporary relief of minor headaches and migraines, applied directly to the temples and forehead using a wax-based stick applicator resembling a lipstick tube.^[6] The product is non-ingested and intended for external use only, targeting symptoms such as throbbing pain, tension, and associated migraine discomfort through repeated application as needed.^[6] The active ingredients consist of highly diluted homeopathic substances: Iris versicolor root 12X HPUS (0.2%), traditionally used for throbbing headaches, and Bryonia alba root 12X HPUS (0.08%), indicated for splitting or sharp pain.^[6] Inactive components include diazolidinyl urea, ethyl alcohol, iodopropynyl butylcarbamate, menthyl lactate, propylene glycol, sodium stearate, steareth-21, tetrasodium EDTA, triethanolamine, and water, which provide the product's texture, scent, and stability.^[6] HeadOn is packaged in 0.2 oz (5.67 g) sticks, offering up to 100 applications per unit.^[7] It is available over-the-counter in pharmacies, grocery stores, and online retailers as of 2025, typically priced between $8 and $10 per stick.^[7] As a homeopathic drug, HeadOn is classified under FDA guidelines for over-the-counter products, with components monographed in the Homeopathic Pharmacopoeia of the United States (HPUS); its 12X dilutions result in concentrations too low to contain measurable amounts of the original substances.^[6]

Development and Launch

HeadOn was developed in the early 2000s by Miralus Healthcare, a Florida-based company founded in 2003 and specializing in homeopathic remedies. The product emerged from several years of research into homeopathic formulations for headache relief, drawing on traditional homeopathic principles such as the use of highly diluted substances to stimulate the body's natural healing responses. Miralus executives focused on creating a non-pharmacological, topical alternative amid growing consumer interest in complementary and alternative medicine, with surveys indicating that 62% of U.S. adults had used at least one such approach in 2002. This emphasis addressed demands for natural options free from the side effects commonly associated with nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. The product was first introduced to the market as a niche over-the-counter remedy around 2004, becoming widely available by 2005 through retailers such as Wal-Mart. It gained broader distribution in 2005–2006, supported by an aggressive advertising push that elevated its profile among consumers seeking homeopathic solutions. HeadOn is manufactured in the United States, adhering to FDA-compliant standards for homeopathic drugs, which require compliance with the Homeopathic Pharmacopeia of the United States but do not mandate pre-market efficacy testing. Initial marketing positioned HeadOn as a safe, fast-acting option for headache and migraine relief, targeting individuals wary of conventional pharmaceuticals and highlighting its non-greasy, portable applicator design for convenient use. Dan Charron, Miralus Healthcare's vice president of sales and marketing, described it as a remedy that works by stimulating the body to overcome pain rather than merely masking symptoms. Early sales remained modest, totaling about $1.9 million in 2005, reflecting its status as a specialized product before the advertising surge. The 2006 television commercial further amplified visibility, contributing to subsequent growth.

Advertising and Marketing

The Infamous Commercial

The infamous 2006 television advertisement for HeadOn was a 15-second spot featuring a brunette model applying the product's roll-on applicator to her forehead against a plain, monochromatic background, accompanied by a voiceover repeating the tagline "HeadOn: Apply directly to the forehead" three times with no additional explanatory text or details about the product's composition or benefits.^[4]^[8] The commercial was produced in-house by Miralus Healthcare, the Florida-based company marketing HeadOn, in mid-2006, reflecting its simplistic and amateurish aesthetic without external agency involvement.^[8] It debuted on cable networks including CNN and ESPN in June 2006, targeting a broad audience during daytime, prime time, and late-night slots.^[9]^[10] Miralus Healthcare developed the ad's repetition strategy based on focus group testing, where participants recalled repetitive versions far better than alternatives that included scientific explanations or ingredient details; the company deliberately omitted such information to maintain brevity and comply with advertising guidelines, drawing on infomercial techniques for memorability despite acknowledging the potential for viewer annoyance.^[8] The spot aired extensively across national cable and syndicated television from mid-2006 through the late 2000s, with minor variations promoting HeadOn's migraine-specific formula, achieving saturation through an initial ad spend of about $15 million in measured media during 2006 alone and a projected total of $70 million for 2007.^[11] This investment enabled widespread exposure, contributing to the product's sales growth of 234% from 2005 to 2006.^[12] The campaign tapered off in the late 2000s amid regulatory scrutiny.

Public Reception and Cultural Impact

The HeadOn commercial elicited a mixed initial audience reaction upon its debut in 2006, with viewers praising its catchy simplicity while widely mocking its repetitive structure, which led to widespread descriptions of it as a prime example of "annoyance marketing."^[4]^[2] Media outlets highlighted how the ad's relentless tagline—"HeadOn: Apply directly to the forehead!"—created irritation that paradoxically boosted recall, positioning it as an effective, if polarizing, advertising tactic.^[8] Despite the backlash, the commercial significantly boosted sales for HeadOn, transforming it into one of the top-selling homeopathic remedies in the U.S. by the late 2000s, with revenue reportedly surging from modest figures in 2005 to substantial growth driven by the ad's ubiquity.^[13] This success underscored the ad's role in elevating a niche product to mainstream visibility, even as consumers expressed frustration over its frequency on television.^[14] The spot quickly became a cultural phenomenon, emerging as a viral meme in the pre-social media era through word-of-mouth, online forums, and comedy references, including parodies on Saturday Night Live that amplified its notoriety.^[14] The phrase "apply directly to the forehead" entered everyday language as a humorous shorthand for absurd or overly simplistic solutions, appearing in sketches, blogs, and casual conversations.^[15] In media coverage, HeadOn served as a case study in "irritainment"—advertising that leverages annoyance for memorability—with analyses praising its low-cost production and high impact on consumer awareness.^[16] Retrospectives in the 2020s, such as YouTube videos dissecting the ad's legacy, have garnered significant online attention.^[17] HeadOn's long-term legacy includes its role in discussions of repetitive ad formats in advertising education, demonstrating how provocation can drive cultural penetration and sales without conventional storytelling.^[14]^[16]

Efficacy and Scientific Scrutiny

Claimed Mechanism

HeadOn operates on homeopathic principles, primarily the "like cures like" doctrine established by Samuel Hahnemann in the late 18th century, which posits that substances producing symptoms similar to a disease in healthy individuals can stimulate the body's innate healing response when administered in highly diluted forms.^[18] The product's active ingredients, Iris versicolor root and Bryonia alba root, both at 12X dilution (equivalent to a 1:10^12 ratio), are selected for their symptom profiles matching headache and migraine characteristics; Iris versicolor is indicated for intense migraines accompanied by blurred vision, facial pain, and gastric disturbances, while Bryonia alba addresses bursting headaches worsened by motion, noise, and light sensitivity.^[19] According to statements from Miralus Healthcare, the manufacturer, HeadOn works by stimulating the body's natural mechanisms to overcome headache or migraine symptoms, rather than merely masking pain as conventional analgesics do.^[20] This topical preparation is applied directly to the forehead and temples, purportedly allowing the diluted ingredients to interact with the body's vital force without systemic absorption, thereby avoiding side effects such as drowsiness or gastrointestinal upset associated with drugs like ibuprofen.^[21] The high dilutions align with Hahnemann's framework in the Organon of Medicine, ensuring minimal material substance while enhancing safety through potentization, a process of serial dilution and succussion believed to imprint therapeutic information onto the remedy.^[18] Dosage instructions specify application for adults and children over 12 at the first sign of headache, covering the entire forehead as needed, with consultation for younger children; this localized use is claimed to provide targeted relief by engaging the body's self-regulatory processes at the site of pain.^[1] Miralus positions HeadOn as a non-invasive alternative to pharmaceutical options, emphasizing its homeopathic foundation to promote holistic symptom resolution without interference from adverse reactions.^[20]

Evidence and Criticisms

HeadOn has not been the subject of any peer-reviewed, double-blind clinical trials demonstrating its efficacy for relieving headaches or migraines. Reviews by medical experts, including those cited in Consumer Reports, have attributed any perceived benefits to the placebo effect or the physical act of applying the product, such as a massaging motion on the temples.^[22] The scientific consensus holds that homeopathic remedies like HeadOn, which rely on extreme dilutions often exceeding Avogadro's limit (approximately 12C potency, or 1 part in 10^24), contain negligible or no active molecules, making their therapeutic claims implausible and pseudoscientific. A comprehensive analysis of over 200 research papers published in The Lancet confirmed that homeopathy performs no better than placebo across various conditions, including pain relief.^[23] While the product's formulation may provide a minor cooling sensation similar to menthol, this sensory effect is not linked to the homeopathic principles and does not substantiate claims of targeted headache relief. Anecdotal user testimonials, such as those on retail sites like Amazon, frequently report headache relief, with positive reviews outnumbering negative ones by about two to one; however, analyses in the 2010s, including a Skeptical Inquirer investigation, emphasized that such reports likely stem from placebo responses rather than pharmacological action, as controlled comparisons show no superiority over inert treatments.^[24] Expert critiques from headache specialists underscore the risks of relying on unproven homeopathics for migraine management, with organizations like the American Headache Society advocating evidence-based therapies over alternatives lacking rigorous validation. The U.S. Food and Drug Administration (FDA) explicitly does not evaluate homeopathic products for efficacy, allowing their marketing under a compliance policy that exempts them from standard drug approval processes, a stance criticized for potentially misleading consumers. In July 2025, a U.S. District Court upheld the FDA's authority to regulate homeopathic products under standard drug laws, potentially impacting future marketing of unproven remedies.^[25]^[26] As of 2025, no new clinical studies on HeadOn have emerged, maintaining its status as unsupported by modern evidence; consumer advocacy reports continue to rate it poorly for evidence-based relief, recommending over-the-counter options like acetaminophen, which have demonstrated efficacy in randomized trials for acute headache pain.^[22]

Regulatory History and Controversies

Advertising Complaints

In 2006, the National Advertising Division (NAD) of the Council of the Better Business Bureaus reviewed advertising for HeadOn after challenges to its unsubstantiated claims of providing "fast, safe, effective" relief from headaches and migraines. The NAD determined that Miralus Healthcare, the product's manufacturer, lacked sufficient scientific evidence to support these efficacy assertions, prompting the company to discontinue such explicit claims in its advertisements. Instead, Miralus agreed to qualify future promotions by referencing "traditional homeopathic practice," though the brand's signature repetitive commercial format persisted without alteration.^[10]^[27] Consumer complaints about HeadOn's advertising surged during this period, with reports to the Better Business Bureau highlighting concerns over false or misleading representations of the product's benefits. These grievances contributed to the NAD's scrutiny and led to modifications in ad content, such as the inclusion of directives like "use only as directed" to temper implied effectiveness. No specific fines were imposed, but the complaints underscored broader dissatisfaction with the promotion of homeopathic remedies lacking robust clinical backing.^[2] Media coverage amplified these issues, notably in a September 2007 Consumer Reports article that criticized HeadOn for insufficient evidence of efficacy, fueling public calls for regulatory bans on similar unsubstantiated claims. While no enforcement actions resulted in penalties at the time, this scrutiny influenced subsequent federal guidance on homeopathic advertising. In particular, it contributed to evolving standards that emphasized the need for disclaimers in promotions of over-the-counter homeopathic drugs.^[28] Following these early challenges, regulatory oversight of homeopathic advertising intensified. The Federal Trade Commission (FTC) issued a 2016 enforcement policy statement requiring that claims for over-the-counter homeopathic products be substantiated by competent and reliable scientific evidence, or accompanied by clear and conspicuous disclaimers stating that such claims lack FDA evaluation. As of 2025, no recent formal complaints or inquiries regarding HeadOn's advertising have been documented, and any ongoing promotions appear to align with these updated FTC requirements on efficacy assertions and testimonials.^[29]

Safety and Legal Concerns

Early formulations of HeadOn contained potassium dichromate as an active ingredient, a compound classified as a human carcinogen and known to cause severe skin burns, eye damage, and allergic skin reactions upon contact.^[30]^[31] This substance, used industrially for purposes like photography development, raised significant safety concerns due to its toxicity, prompting scrutiny over its inclusion in a topical product applied directly to the skin.^[32] Following these warnings, the product was reformulated, and current versions list iris versicolor and bryonia alba as active ingredients, with no potassium dichromate present.^[6] Reported side effects from HeadOn use are rare but include allergic reactions such as skin rashes, from inactive ingredients.^[6] The product labeling advises against use by those allergic to any ingredient, with sensitive skin, or with skin diseases, and recommends discontinuing if irritation occurs.^[6] No widespread reports of severe adverse events have been documented, and there have been no major product recalls. In 2008, a class-action lawsuit was filed against Miralus Healthcare in Los Angeles Superior Court, alleging that HeadOn products were neither safe nor effective and contained potentially carcinogenic chemicals like potassium dichromate, along with deceptive labeling practices.^[33] The suit claimed violations of consumer protection laws due to unsubstantiated health claims and safety risks. It was settled out of court, though specific terms regarding refunds were not publicly detailed. As a homeopathic product, HeadOn falls under FDA oversight for low-risk over-the-counter drugs but has not been evaluated for safety or efficacy by the agency.^[6] The FDA's 2017 warning letters to several homeopathic manufacturers for current good manufacturing practice violations prompted industry-wide label updates, including disclaimers on unevaluated safety and efficacy, which HeadOn now includes.^[34] As of 2025, no active lawsuits or regulatory actions against the product are reported, and its DailyMed listing confirms compliance with required warnings for sensitive skin users.^[6]

Company and Product Line

Miralus Healthcare

Miralus Healthcare was established in 2003 in Plantation, Florida, with an initial emphasis on developing and marketing homeopathic and natural remedies.^[11] The company launched its first product, RenewIn, a homeopathic joint care product, in 2004, before introducing HeadOn in 2004 as a key offering for headache relief.^[11]^[22] Headquartered in Cheyenne, Wyoming, following a relocation from Florida, Miralus operates as a small enterprise with an estimated workforce of 51 to 100 employees.^[11]^[35] Its business model centers on direct-to-consumer online sales and wholesale distribution to drug stores and retailers across the United States.^[22]^[2] Miralus expanded internationally in the mid-2000s, establishing operations in Canada to support broader market access.^[2] After the late-2000s peak driven by HeadOn, the company adapted by prioritizing e-commerce channels amid reduced reliance on traditional television advertising.^[36] As of 2025, Miralus remains operational, with HeadOn serving as its flagship product, as indicated by active listings on regulatory databases such as DailyMed; although the company website is inactive, products continue to be available through third-party online retailers.^[6]^[35]^[7] HeadOn's product line expanded in the mid-2000s to include variants targeting specific headache types while retaining the topical stick applicator and homeopathic formulation of the original. The HeadOn Migraine variant, advertised as early as 2006, focuses on migraine symptoms and shares the core delivery method for direct application to the temples and forehead.^[37] Other extensions include HeadOn Extra Strength, which incorporates active ingredients such as Kali Bichromicum 6X HPUS and Bryonia Alba 12X HPUS at concentrations of 0.05% and 0.04%, respectively, aimed at more intense headache relief. A separate Extra Strength formulation addresses sinus-related headaches with ingredients like Potassium Bichromate, White Bryony, and Golden Seal. Early product reports from 2005 also describe variants such as HeadOn P.M. (with Potassium Bichromate for nighttime use), Children's formula, and Tension Headache relief, each adjusted with distinct active homeopathic components to suit user needs like reduced sensitivity for younger users or evening application.^[7]^[38]^[20] These variants maintain the foundational wax-based, non-greasy composition but differentiate through targeted symptom relief, such as sinus pressure or tension, with pricing generally between $5 and $8 per unit. Sales of these extensions have trailed the original HeadOn, which drove substantial revenue growth for Miralus Healthcare in the late 2000s, including a reported 234% increase in HeadOn sales from 2005 to 2006.^[38]^[11] As of 2025, the core HeadOn, Migraine, and Extra Strength variants continue to be available primarily through online platforms like Instacart and specialty pharmacies, though major retailers such as Walmart no longer stock them widely; no new product launches have occurred since the early 2010s, and at least two versions remained in production as recently as 2016.^[7]^[32]

References

[1]
HEADON ® - DailyMed
Directions · Adults and children 12 years and older: · remove white outer cap · remove clear inner cap by tilting it to the side · apply directly to forehead at ...
[2]
Ad Nauseam - Los Angeles Times
Jul 23, 2006 · HeadOn is made by a company called Miralus Healthcare, which has offices in Canada and Florida (the actual product is manufactured in Chicago).
[3]
Doctor: 'Head On' No Headache Cure - CBS News
Aug 2, 2006 · "The issues with a product like this are that, sometimes, headaches come, last for a few hours, and go away. And if you rub this on your head ...Missing: topical | Show results with:topical
[4]
Taking an Annoying Pain Commercial Head On - NPR
Jul 10, 2006 · In this commercial, a woman, against a monochromatic background, rubs what looks like a glue stick on her forehead - back and forth, while the HeadOn mantra is ...<|control11|><|separator|>
[5]
[PDF] Diving HeadOn into Pseudoscience - Skeptical Inquirer
The product, sold in drug stores and online for $25, claims to relieve headache and migraine pain. It is neither a pill nor a solution but instead a waxy paste.
[6]
HEADON ULTIMATE RELIEF- iris versicolor root and bryonia alba ...
Use. Temporarily relieves the symptoms of headache and migraine pain.Missing: stimulates body
[7]
Head On Headache Pain Reliever, Extra Strength - Instacart
Same-day deliveryHomeopathic. Headache relief. Apply directly to forehead. Safe & effective. Invisible & non-greasy. Safe to use with other medications. Can be used as often as ...
[8]
The mesmerizing ad for HeadOn.
Jul 24, 2006 · HeadOn is meant to treat headaches and is a gel suffused with various plant extracts that you apply—say it with me—directly to the forehead ...Missing: Miralus Healthcare<|separator|>
[9]
Dude, Don't You Hate Our Commercials? - ADWEEK
Sep 25, 2006 · Although Miralus isn't spending much on the campaign (about $3 million in measured media for the first two months of the effort, the most recent ...Missing: early | Show results with:early<|control11|><|separator|>
[10]
HeadOn (Advertising) - TV Tropes
The notorious advertisement, which first aired in June 2006, stemmed from Better Business Bureau objections to the earlier ads' claims of "fast, safe, ...
[11]
Headache remedy becomes pop culture phenom - UPI.com
Jul 31, 2006 · "We did not intend to make a joke out of this or a parody," says Dan Charron, a vice president of HeadOn's maker, Miralus Healthcare of ...Missing: CEO | Show results with:CEO
[12]
This ad will give you a headache, but it sells: HeadOn sales up 234%
Sep 24, 2007 · Miralus' ActivOn, for joint pain, launched in 2006, has leapfrogged past HeadOn, topping out at $5.5 million in sales and jumping to the No.
[13]
Cheesy HeadOn Commercials Cure Sales Woes - MediaPost
From 2005 to 2006, HeadOn grew 234%, according to Information Resources Inc. And for the first half of 2007, the brand looks to be on track to double sales.Missing: early | Show results with:early
[14]
This Ad Will Give You a Headache, but It Sells - Ad Age
Sep 23, 2007 · Clutter buster: HeadOn ads seem amateurish and mindnumbing, but the company's marketing chief said consumers remember them.<|separator|>
[15]
HeadOn: An Annoying Ad that Works - RetailWire
Dan Charron, VP-sales and marketing at Miralus Healthcare, the marketer of HeadOn, recently told AdAge the commercials, which are done in-house, are ...
[16]
HeadOn | Know Your Meme
Dec 16, 2009 · HeadOn is a homeopathic product used to treat headaches. It should be noted that the commercial used to distribute said product may be a direct cause of its ...
[17]
Does Irritating Your Customers Work? - Neuromarketing
One of the most annoying series of commercials is for HeadOn, an analgesic which one rubs on one's forehead to (supposedly) cure headaches. Does HeadOn work ...Missing: case | Show results with:case
[18]
HeadOn | The Story Behind the STRANGEST Ad - YouTube
Dec 21, 2022 · Head-on was an over-the-counter medicine wax stick that you rubbed on your forehead to provide pain relief from headaches and migraines.Missing: topical | Show results with:topical
[19]
A brief history of homeopathy - PMC - NIH
By a process he called 'proving', Hahnemann claimed to be able to compile a selection of appropriate remedies. This led to his famous aphorism, 'like cures like ...
[20]
Migraine Headaches (Homeopathy) – Health Information Library
Iris versicolor. Intense migraines with blurry vision and pain that extends to the face and teeth, along with vomiting and a burning feeling in the throat ...
[21]
Healing head pains | Archived News - The Daily Collegian
Oct 18, 2005 · HeadOn works by "stimulating your body to overcome a headache or migraine," Charron said, instead of masking symptoms "like conventional ...Missing: development history
[22]
Health Consciousness – Apply Bamboozlement Directly to The ...
Aug 24, 2007 · The vice president of sales and marketing for Miralus has stated that HeadOn works by ?stimulating your body to overcome a headache or migraine?
[23]
Head-Desking HeadOn! | Center for Inquiry
Aug 31, 2016 · “Apply directly to the forehead,” infamously commanded a TV commercial for HeadOn, a pain reliever introduced in 2006 by a company called ...
[24]
Diving HeadOn into Pseudoscience | Skeptical Inquirer
Benjamin Radford, M.Ed., is a scientific paranormal investigator, a research fellow at the Committee for Skeptical Inquiry, deputy editor of the Skeptical ...Missing: analysis | Show results with:analysis
[25]
Some Homeopathic Products May Put You at Risk - FDA
Jan 13, 2025 · Homeopathic products are marketed without FDA review and may not meet modern standards for safety, effectiveness, quality and labeling.Missing: efficacy | Show results with:efficacy
[26]
Head Rub - The Washington Post
Sep 25, 2006 · HeadOn claims to relieve headaches through homeopathic means -- by administering minute doses of agents said to cause the pain.Missing: development history
[27]
FTC Issues Enforcement Policy Statement Regarding Marketing ...
Nov 15, 2016 · The policy statement explains that the FTC will hold efficacy and safety claims for OTC homeopathic drugs to the same standard as other products making similar ...Missing: exemption | Show results with:exemption
[28]
[PDF] Hazardous Substance Fact Sheet - NJ.gov
▻ Potassium Dichromate is a CARCINOGEN in humans. There is evidence that Hexavalent Chromium or Chromium. VI Compounds cause lung cancer in humans and animals.
[29]
ICSC 1371 - POTASSIUM DICHROMATE - INCHEM
This substance is carcinogenic to humans. Animal tests show that this substance possibly causes toxicity to human reproduction or development. OCCUPATIONAL ...
[30]
HeadOn Headache Product Potentially Dangerous
Jul 13, 2006 · The active ingredient in HeadOn, a roll-on headache treatment, is potassium dicromate, which is used in developing photos and should not come into contact with ...<|control11|><|separator|>
[31]
Beeswax - Uses, Side Effects, and More - WebMD
While rare, some people may have an allergic reaction to beeswax. When applied to the skin: Beeswax is LIKELY SAFE for most people when applied directly to the ...Missing: HeadOn | Show results with:HeadOn
[32]
Class-Action Complains Of Headache Drugs
Miralus Healthcare sells several "HeadOn" headache remedies that are neither safe nor effective, and contain chemicals that may be carcinogenic.Missing: 2002 | Show results with:2002
[33]
Homeolab USA Inc. - 523072 - 08/02/2017 - FDA
Aug 2, 2017 · This warning letter summarizes significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals.
[34]
Miralus Healthcare Overview | Salary.com
Discover essential details about Miralus Healthcare, including address, contact, and journey of our company's evolution.
[35]
Statement From Miralus Healthcare - Makers Of HeadOn
May 7, 2008 · HeadOn is a homeopathic product with small dosages, based on the Homeopathic Pharmacopeia, and has received positive consumer feedback and high ...Missing: Austria history
[36]
The Gazette from Cedar Rapids, Iowa • 156 - Newspapers.com
Feb 26, 2006 · New! Homeopathic migraine relief! HEADON HEADON! Apply directly Apply directly to forehead to forehead HEADON HEADON MIGRAINE EXTRA STRENGTH ...
[37]
HeadOn - Bionity
Dec 23, 2007 · HeadOn is a topical product intended for headache relief, produced by Miralus Healthcare, which claims it is a homeopathic remedy.